Skip to main content

Market Overview

36 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) stock surged 35.0% to $2.16 during Monday's pre-market session. The market cap seems to be at $215.6 million. The most recent rating by JMP Securities, on October 07, is at Market Outperform, with a price target of $21.00.
  • Medicines Co, Inc. (NASDAQ: MDCO) stock increased by 23.1% to $84.40. The market cap stands at $4.1 billion. The most recent rating by Baird, on November 25, is at Neutral, with a price target of $85.00.
  • Enochian BioSciences, Inc. (NASDAQ: ENOB) shares surged 19.2% to $7.00. The market cap seems to be at $263.7 million.
  • Aquestive Therapeutics, Inc. (NASDAQ: AQST) stock rose 18.2% to $7.60. The market value of their outstanding shares is at $96.1 million.
  • AnaptysBio, Inc. (NASDAQ: ANAB) stock surged 15.2% to $13.85. The market cap stands at $1.0 billion. According to the most recent rating by Guggenheim, on November 08, the current rating is at Neutral.
  • Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares surged 7.6% to $115.00. The market value of their outstanding shares is at $9.6 billion. The most recent rating by Barclays, on November 21, is at Overweight, with a price target of $131.00.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) shares surged 6.9% to $1.87. The market value of their outstanding shares is at $42.4 million.
  • ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) stock rose 6.8% to $5.04. The market cap seems to be at $763.9 million.
  • Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) stock moved upwards by 6.3% to $94.50. The market cap seems to be at $2.3 billion. The most recent rating by UBS, on November 12, is at Buy, with a price target of $135.00.
  • Myovant Sciences, Inc. (NYSE: MYOV) shares moved upwards by 6.0% to $14.90. The market cap seems to be at $489.3 million. The most recent rating by Goldman Sachs, on August 28, is at Buy, with a price target of $20.00.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares moved upwards by 6.0% to $52.16. The market value of their outstanding shares is at $2.6 billion. The most recent rating by Baird, on November 25, is at Outperform, with a price target of $70.00.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) stock increased by 5.3% to $9.12. The market cap stands at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX) shares moved upwards by 4.7% to $89.00. The market value of their outstanding shares is at $325.9 million. The most recent rating by Goldman Sachs, on November 18, is at Buy, with a price target of $109.00.
  • Viveve Medical, Inc. (NASDAQ: VIVE) stock increased by 4.4% to $0.96. The market cap stands at $6.8 million. The most recent rating by Stifel Nicolaus, on November 07, is at Hold, with a price target of $1.00.
  • BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares moved upwards by 4.0% to $2.34. The market cap seems to be at $220.8 million. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.
  • Canopy Growth, Inc. (NYSE: CGC) shares increased by 3.8% to $19.10. The market cap seems to be at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Zealand Pharma, Inc. (NASDAQ: ZEAL) stock rose 3.7% to $31.16. The market cap stands at $1.0 billion. According to the most recent rating by Jefferies, on November 19, the current rating is at Hold.
  • Organogenesis Holdings, Inc. (NASDAQ: ORGO) shares increased by 3.7% to $4.90. The market cap seems to be at $664.1 million.
  • Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) stock rose 3.6% to $10.34. The market cap stands at $511.0 million.
  • Mylan, Inc. (NASDAQ: MYL) shares increased by 3.5% to $17.95. The market cap stands at $9.8 billion. The most recent rating by Morgan Stanley, on November 07, is at Equal-Weight, with a price target of $18.00.
  • Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) shares increased by 3.2% to $0.32. The market value of their outstanding shares is at $3.9 million.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) stock increased by 2.9% to $1.08. The market cap stands at $7.6 million. The most recent rating by Maxim Group, on September 06, is at Buy, with a price target of $2.00.
  • Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) stock surged 2.7% to $10.50. The market value of their outstanding shares is at $8.9 billion. According to the most recent rating by JP Morgan, on November 12, the current rating is at Neutral.
  • CRISPR Therapeutics, Inc. (NASDAQ: CRSP) stock surged 2.6% to $63.85. The market cap stands at $2.7 billion. The most recent rating by Oppenheimer, on November 12, is at Outperform, with a price target of $65.00.
  • Ocugen, Inc. (NASDAQ: OCGN) shares increased by 2.6% to $0.29. The market cap seems to be at $19.7 million.

 

Losers

  • CymaBay Therapeutics, Inc. (NASDAQ: CBAY) stock plummeted 79.6% to $1.13 during Monday's pre-market session. The market cap seems to be at $308.4 million.
  • Adamis Pharmaceuticals, Inc. (NASDAQ: ADMP) stock declined 52.4% to $0.60. The market value of their outstanding shares is at $49.7 million.
  • ASLAN Pharmaceuticals, Inc. (NASDAQ: ASLN) shares fell 24.3% to $1.31. The market value of their outstanding shares is at $49.3 million. The most recent rating by H.C. Wainwright, on November 14, is at Buy, with a price target of $2.00.
  • InVivo Therapeutics Hldg, Inc. (NASDAQ: NVIV) shares fell 12.1% to $0.14. The market cap stands at $4.3 million.
  • Phio Pharmaceuticals, Inc. (NASDAQ: PHIO) stock declined 7.8% to $0.12. The market cap seems to be at $5.7 million.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares decreased by 5.7% to $0.20. The market value of their outstanding shares is at $20.3 million.
  • OrganiGram Holdings, Inc. (NASDAQ: OGI) shares declined 4.9% to $2.51. The market cap seems to be at $536.7 million.
  • OpGen, Inc. (NASDAQ: OPGN) stock plummeted 3.9% to $1.22. The market cap seems to be at $4.5 million.
  • Genfit, Inc. (NASDAQ: GNFT) stock plummeted 3.8% to $14.65. The market value of their outstanding shares is at $552.9 million.
  • Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) stock plummeted 3.7% to $6.83. The market cap stands at $14.3 million.
  • VBI Vaccines, Inc. (NASDAQ: VBIV) stock fell 3.2% to $0.62. The market cap seems to be at $104.2 million. The most recent rating by Raymond James, on November 14, is at Outperform, with a price target of $3.00.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) stock declined 2.9% to $0.15. The market cap stands at $4.3 million.
 

Related Articles (ALNY + ADMP)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com